🇺🇸 FDA
Patent

US 10117942

Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery

granted A61KA61K31/704A61K41/0042

Quick answer

US patent 10117942 (Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/704, A61K41/0042, A61K41/0071, A61K47/546